Momentis Surgical’s Anovo Becomes First Triple-Approach Robot
FORT LAUDERDALE, Fla. & TEL AVIV, Israel, July 23, 2026 Momentis Surgical has received U.S. Food and Drug Administration...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
FORT LAUDERDALE, Fla. & TEL AVIV, Israel, July 23, 2026 Momentis Surgical has received U.S. Food and Drug Administration...
PITTSBURGH, USA & BIRMINGHAM, UK, July 23, 2026 MolecuLight and The Royal Orthopaedic Hospital NHS Foundation Trust (ROH) have...
SUNNYVALE, Calif., July 23, 2026 VELMENI AI has received U.S. Food and Drug Administration (FDA) 510(k) clearance for VELMENI...
Westlake, Texas, USA – May 21, 2026 Virbac, a global leader in animal health and veterinary care, announced that...
McLean, Virginia, USA – May 20, 2026 Oryx Dental, a rapidly growing provider of cloud-based and AI-powered dental practice...
JERUSALEM – May 8, 2026 Alpha Tau Medical Ltd. announced the completion of patient enrollment in its pivotal U.S....
SEOUL, South Korea and ALISO VIEJO, Calif. – May 7, 2026 Medit Corp., a global leader in digital dentistry...
